301 related articles for article (PubMed ID: 9618731)
21. Manipulating the renin-angiotensin system: more than we bargained for?
Gardner DG
Am J Med; 2002 Feb; 112(2):152-3. PubMed ID: 11835956
[No Abstract] [Full Text] [Related]
22. Pressure, platelets, and plaque: the central role of angiotensin II in cardiovascular pathology. Introduction.
Arakawa K
Am J Cardiol; 2001 Apr; 87(8A):1C-2C. PubMed ID: 11334761
[No Abstract] [Full Text] [Related]
23. The physiological significance of the alternative pathways of angiotensin II production.
Kramkowski K; Mogielnicki A; Buczko W
J Physiol Pharmacol; 2006 Dec; 57(4):529-39. PubMed ID: 17229979
[TBL] [Abstract][Full Text] [Related]
24. Therapeutic potential of renin inhibitors in the management of cardiovascular disorders.
Stanton A
Am J Cardiovasc Drugs; 2003; 3(6):389-94. PubMed ID: 14728059
[TBL] [Abstract][Full Text] [Related]
25. Local renin-angiotensin systems: the unanswered questions.
Danser AH
Int J Biochem Cell Biol; 2003 Jun; 35(6):759-68. PubMed ID: 12676161
[TBL] [Abstract][Full Text] [Related]
26. [What have we learned from converting enzyme inhibitors on renin-angiotensin system?].
Waeber B; Nussberger J; Brunner HR
Rev Prat; 1992 Dec; 42(20):2529-32. PubMed ID: 1338608
[TBL] [Abstract][Full Text] [Related]
27. [Network regulation of renin-angiotensin system on the cardiovascular diseases].
Yang H; Wang HX; Li HH
Sheng Li Ke Xue Jin Zhan; 2013 Jun; 44(3):183-7. PubMed ID: 24027824
[TBL] [Abstract][Full Text] [Related]
28. The role of the brain renin-angiotensin system in neurodegenerative disorders.
Savaskan E
Curr Alzheimer Res; 2005 Jan; 2(1):29-35. PubMed ID: 15977987
[TBL] [Abstract][Full Text] [Related]
29. Brain angiotensin: pathways and pharmacology.
Unger T; Badoer E; Ganten D; Lang RE; Rettig R
Circulation; 1988 Jun; 77(6 Pt 2):I40-54. PubMed ID: 2836110
[TBL] [Abstract][Full Text] [Related]
30. Measurement of the renin-angiotensin system in heart failure.
Kim SD
Biol Res Nurs; 2000 Jan; 1(3):210-26. PubMed ID: 11232216
[TBL] [Abstract][Full Text] [Related]
31. Effect of chronic captopril treatment on circulating and tissue renin-angiotensin system in SHR rats.
Hu WY; Chen DG; Chen SC; Jin XQ; Wang HJ
Zhongguo Yao Li Xue Bao; 1996 Nov; 17(6):507-12. PubMed ID: 9863143
[TBL] [Abstract][Full Text] [Related]
32. Targeting the renin-angiotensin system: what's new?
Leckie BJ
Curr Med Chem Cardiovasc Hematol Agents; 2005 Jan; 3(1):23-32. PubMed ID: 15638741
[TBL] [Abstract][Full Text] [Related]
33. Renin-angiotensin system blockade at the level of the angiotensin converting enzyme or the angiotensin type-1 receptor: similarities and differences.
Stergiou GS; Skeva II
Curr Top Med Chem; 2004; 4(4):473-81. PubMed ID: 14965313
[TBL] [Abstract][Full Text] [Related]
34. [Prospective trends in the study of the therapeutic action of angiotensin-converting enzyme inhibitors in cardiovascular diseases].
Novikova LS; Arabidze GG
Ter Arkh; 1990; 62(1):118-23. PubMed ID: 2159193
[No Abstract] [Full Text] [Related]
35. Molecular genetics of the renin-angiotensin system: implications for angiotensin II receptor blockade.
Davis GK; Roberts DH
Pharmacol Ther; 1997; 75(1):43-50. PubMed ID: 9364580
[TBL] [Abstract][Full Text] [Related]
36. Newly recognized components of the renin-angiotensin system: potential roles in cardiovascular and renal regulation.
Carey RM; Siragy HM
Endocr Rev; 2003 Jun; 24(3):261-71. PubMed ID: 12788798
[TBL] [Abstract][Full Text] [Related]
37. Antifibrotic peptide N-acetyl-Ser-Asp-Lys-Pro (Ac-SDKP): opportunities for angiotensin-converting enzyme inhibitor design.
Douglas RG; Ehlers MR; Sturrock ED
Clin Exp Pharmacol Physiol; 2013 Aug; 40(8):535-41. PubMed ID: 23351021
[TBL] [Abstract][Full Text] [Related]
38. Angiotensin II: biosynthesis, molecular recognition, and signal transduction.
Riordan JF
Cell Mol Neurobiol; 1995 Dec; 15(6):637-51. PubMed ID: 8719034
[TBL] [Abstract][Full Text] [Related]
39. Modulation of renal glomerular angiotensin II receptors by ace inhibition and AT1 receptor antagonism.
Haddad G; Amiri F; Garcia R
Regul Pept; 1997 Jan; 68(2):111-7. PubMed ID: 9110382
[TBL] [Abstract][Full Text] [Related]
40. Angiotensin II type 1 receptor blockade: a new development in cardiovascular pharmacology.
Leary AC; MacDonald TM
Int J Clin Pract; 1998 Oct; 52(7):475-81. PubMed ID: 10622089
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
